Delivery Order SPE2DB22D1017-SPE2DB24FF3XZ
Award Date
3/8/24
Potential Completion Date
3/11/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $31,160.74 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, a specialty pharmaceutical product. The contract has a completion date of May 11, 2023. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml syringes. The contract has a ceiling value of $2,246.43 and is a firm fixed-price delivery order with an ultimate completion date of December 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999, which serves as the primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,568.72 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, with a completion date of June 1, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml syringes. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp, a division of parent company Cencora, Inc., is a Delivery Order valued at $49,738.83 for the supply of Dupixent 300 mg/2 ml syringes. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which...
The U.S. Defense Logistics Agency (DLA) awarded a $4,285.15 delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC enables the efficient procurement of a wide range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $9,928.69 and is a delivery order for the supply of Dupixent 300 mg/2 ml syringes. The contract is a firm fixed-price type with a period of performance through May 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Dupixent 300 mg/2 ml syringes. The contract has a ceiling value of $38,757.47 and an ultimate completion date of March 11, 2024. This award is a delivery order placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. The IDC has a...
This federal contract award is a delivery order with a ceiling value of $21,631.92, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of Dupixent 300 mg/2 ml syringes, with an ultimate completion date of October 28, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November...
This federal contract award, valued at $11,074.44, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, a specialty medication, with an ultimate completion date of October 30, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA...